 Immunity, Cellular
"Immunity, Cellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.
| Descriptor ID |
D007111
|
| MeSH Number(s) |
G12.450.050.400
|
| Concept/Terms |
Immunity, Cellular- Immunity, Cellular
- Cellular Immunities
- Cellular Immunity
- Immunities, Cellular
- Cell-Mediated Immunity
- Cell Mediated Immunity
- Cell-Mediated Immunities
- Immunities, Cell-Mediated
- Immunity, Cell-Mediated
Cellular Immune Response- Cellular Immune Response
- Cellular Immune Responses
- Immune Response, Cellular
- Immune Responses, Cellular
- Response, Cellular Immune
|
Below are MeSH descriptors whose meaning is more general than "Immunity, Cellular".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Cellular".
This graph shows the total number of publications written about "Immunity, Cellular" by people in this website by year, and whether "Immunity, Cellular" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 1 | 3 | 4 | | 1998 | 1 | 3 | 4 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 3 | 3 | | 2001 | 2 | 3 | 5 | | 2002 | 1 | 3 | 4 | | 2003 | 3 | 5 | 8 | | 2004 | 1 | 3 | 4 | | 2005 | 2 | 3 | 5 | | 2006 | 2 | 2 | 4 | | 2007 | 3 | 4 | 7 | | 2008 | 3 | 5 | 8 | | 2009 | 1 | 5 | 6 | | 2010 | 4 | 7 | 11 | | 2011 | 3 | 3 | 6 | | 2012 | 3 | 6 | 9 | | 2013 | 4 | 2 | 6 | | 2014 | 5 | 1 | 6 | | 2015 | 1 | 4 | 5 | | 2016 | 5 | 3 | 8 | | 2017 | 3 | 0 | 3 | | 2018 | 11 | 2 | 13 | | 2019 | 8 | 1 | 9 | | 2020 | 3 | 1 | 4 | | 2021 | 4 | 1 | 5 | | 2022 | 0 | 1 | 1 | | 2023 | 0 | 1 | 1 | | 2024 | 0 | 2 | 2 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunity, Cellular" by people in Profiles.
-
Smith C, Curtis K, Bonham A, Boyer S, Lenz L, Weinberg A. Comparison of immune responses to respiratory syncytial virus in infancy, childhood, and adulthood using an in vitro model of human respiratory infection. Immunohorizons. 2025 Jan 24; 9(2).
-
Kister I, Curtin R, Piquet AL, Borko T, Pei J, Banbury BL, Bacon TE, Kim A, Tuen M, Velmurugu Y, Nyovanie S, Selva S, Samanovic MI, Mulligan MJ, Patskovsky Y, Priest J, Cabatingan M, Winger RC, Krogsgaard M, Silverman GJ. Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2?years after COVID-19 vaccination. Ann Clin Transl Neurol. 2024 Jul; 11(7):1750-1764.
-
Levin MJ, Ginde AA, Schmid DS, Lang N, Canniff J, Schwartz RS, Weinberg A. Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents. Vaccine. 2024 Apr 02; 42(9):2278-2281.
-
Smith CL, Bednarchik B, Aung H, Wilk DJ, Boxer RS, Daddato AE, Wilson BM, Gravenstein S, Canaday DH. Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents. J Infect Dis. 2023 09 15; 228(6):704-714.
-
Levin MJ, Weinberg A. Immune Responses to Varicella-Zoster Virus Vaccines. Curr Top Microbiol Immunol. 2023; 438:223-246.
-
Dutt TS, Karger BR, Fox A, Youssef N, Dadhwal R, Ali MZ, Patterson J, Creissen E, Rampacci E, Cooper SK, Podell BK, Gonzalez-Juarrero M, Obregon-Henao A, Henao-Tamayo M. Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis. Cell Rep. 2022 12 13; 41(11):111783.
-
Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency. J Clin Immunol. 2022 08; 42(6):1137-1150.
-
Johnson MJ, Liu C, Ghosh D, Lang N, Levin MJ, Weinberg A. Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year Persistence. J Infect Dis. 2022 04 19; 225(8):1477-1481.
-
Yanis A, Haddadin Z, Spieker AJ, Waqfi D, Rankin DA, Talj R, Thomas L, Birdwell KA, Ezzell L, Blair M, Eason J, Varjabedian R, Warren CM, Nochowicz CH, Olson EC, Simmons JD, Yoder S, Guy M, Thomsen I, Chappell JD, Kalams SA, Halasa NB. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls. Transpl Infect Dis. 2022 Feb; 24(1):e13772.
-
Yomogida K, Bigley TM, Trsan T, Gilfillan S, Cella M, Yokoyama WM, Egawa T, Colonna M. Hobit confers tissue-dependent programs to type 1 innate lymphoid cells. Proc Natl Acad Sci U S A. 2021 12 14; 118(50).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|